patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
TYENNE
Marketedupdated 2mo agoby Fresenius Kabi USA LLC
Approvedcommunity read0 votes
all catalysts(8)
approval · 8
Mar 5, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Sep 5, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Dec 3, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Dec 13, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Feb 28, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Mar 13, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
May 12, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Jan 21, 2026
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that